Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today?

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

TransCode Therapeutics stock is down on Monday after the company announced plans for a shareholder meeting for RNAZ investors.

The post Why Is TransCode Therapeutics (RNAZ) Stock Down 14% Today? appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.